Differences in survival of prostate cancer Gleason 8–10 disease and the establishment of a new Gleason survival grading system

BACKGROUND: Although the latest Gleason grading system in 2014 has distinguished between Gleason 3 + 4 and 4 + 3, Gleason 8 and Gleason 9–10 are remained systemically classified. METHODS: A total of 261,125 patients diagnosed with prostate cancer (PCa) were selected between 2005 and 2015 from the Su...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Zhou, Yuan, Lin, Changming, Hu, Zhihua, Yang, Cheng, Zhang, Rentao, Ding, Yinman, Wang, Zhengquan, Tao, Sha, Qin, Yanmei
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Clinical Cancer Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7826472/
https://ncbi.nlm.nih.gov/pubmed/33135335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3571
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky